Supplementary Figure 2: Effect of NX and TSP-1: (A) on migration of endothelial cells following treatment of two distinct glioblastoma cells (A172 and GL15); (B) on VEGF released by A172 and GL15 cells. (A)
Migration assay in boyden chamber with HBMECs seeded in the insert and in the well, A172 or GL15 in culture medium. A172 or GL15 were treated with TSP-1, NX or H2O (control). The number of migrating cells was quantified in 4 random images from each treatment group. Results are presented as mean {plus minus} SEM from 3 independent experiments. Observations were performed using a fluorescent light microscope (magnification x20). The capacity of treated glioblastoma cells to induce HBMEC migration is closely linked to the number of migrating cells reflected by fluorescent intensity. (B) VEGF concentration, corresponding to VEGF released by NX or TSP-1 treated A172 or GL15 cells, was quantified by ELISA and absorbance determination by a spectrophotometer (405/650 nm). P value<0.05 was considered significant. In both glioblastoma cell lines, NX treatment significantly decreased VEGF released by cells compared to non-treated cells (SNA172 and GL15) . Comparisons between the treatments and controls were performed by using analysis of variances (ANOVA). * p<0.05; ** p<0.01 ***p<0. Figure 4 was quantified by counting in 4 random images from each treatment group. Results are presented as mean {plus minus} SEM from 3 independent experiments. The vessel density was significantly decreased in NX treated tumors compared to control (p<0.001) or TSP-1(0.0011). Comparisons between the treatments and controls were performed by using analysis of variances (ANOVA). ** p<0.01 ***p<0.001.
